Fulcrum Therapeutics Stock Alpha and Beta Analysis
| FULC Stock | USD 7.06 0.09 1.26% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Fulcrum Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Fulcrum Therapeutics over a specified time horizon. Remember, high Fulcrum Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Fulcrum Therapeutics' market risk premium analysis include:
Beta 2.35 | Alpha (0.16) | Risk 3.93 | Sharpe Ratio 0.0255 | Expected Return 0.1 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Fulcrum |
Fulcrum Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Fulcrum Therapeutics market risk premium is the additional return an investor will receive from holding Fulcrum Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Fulcrum Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Fulcrum Therapeutics' performance over market.| α | -0.16 | β | 2.35 |
Fulcrum Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Fulcrum Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Fulcrum Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Fulcrum Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Fulcrum Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fulcrum Therapeutics shares will generate the highest return on investment. By understating and applying Fulcrum Therapeutics stock market price indicators, traders can identify Fulcrum Therapeutics position entry and exit signals to maximize returns.
Fulcrum Therapeutics Return and Market Media
The median price of Fulcrum Therapeutics for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 is 9.13 with a coefficient of variation of 16.19. The daily time series for the period is distributed with a sample standard deviation of 1.45, arithmetic mean of 8.97, and mean deviation of 1.22. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Acquisition by Tourangeau Greg of 83820 shares of Fulcrum Therapeutics subject to Rule 16b-3 | 01/30/2024 |
2 | 02/26/2024 |
3 | Q2 2024 EPS Estimates for Fulcrum Therapeutics, Inc. Cut by Analyst | 03/01/2024 |
4 | Acquisition by Sapir Alex of 43360 shares of Fulcrum Therapeutics at 11.3475 subject to Rule 16b-3 | 03/04/2024 |
5 | Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference | 03/05/2024 |
6 | Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 03/08/2024 |
7 | Royal Bank of Canada Initiates Coverage on Fulcrum Therapeutics - Defense World | 03/14/2024 |
8 | Disposition of tradable shares by Horn Patrick Taylor of Fulcrum Therapeutics subject to Rule 16b-3 | 03/18/2024 |
9 | Fulcrum Therapeutics Sees Unusually High Options Volume - MarketBeat | 03/25/2024 |
10 | Fulcrum Therapeutics Shares Down 4.6 percent - MarketBeat | 04/03/2024 |
11 | Biotech on a Budget 7 Stocks Under 10 With Huge Potential | 04/15/2024 |
About Fulcrum Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Fulcrum or other stocks. Alpha measures the amount that position in Fulcrum Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.21 | 0.18 | Price To Sales Ratio | 147.54 | 154.91 |
Fulcrum Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Fulcrum Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Fulcrum Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Fulcrum Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Fulcrum Therapeutics. Please utilize our Beneish M Score to check the likelihood of Fulcrum Therapeutics' management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Fulcrum Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Fulcrum Therapeutics Backtesting, Fulcrum Therapeutics Valuation, Fulcrum Therapeutics Correlation, Fulcrum Therapeutics Hype Analysis, Fulcrum Therapeutics Volatility, Fulcrum Therapeutics History and analyze Fulcrum Therapeutics Performance. For information on how to trade Fulcrum Stock refer to our How to Trade Fulcrum Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Fulcrum Stock analysis
When running Fulcrum Therapeutics' price analysis, check to measure Fulcrum Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulcrum Therapeutics is operating at the current time. Most of Fulcrum Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fulcrum Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulcrum Therapeutics' price. Additionally, you may evaluate how the addition of Fulcrum Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Fulcrum Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.